Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2021-03-01
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Function Focused Care: Fracture Care at Home
NCT03147222
A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications
NCT02058329
Geriatric Hip Fractures Caregiver Programme
NCT05393349
Follow-up Home Visits With Nutrition
NCT01249716
Geriatrician-performed Comprehensive Geriatric Care in an Outpatient Community Rehabilitation Unit
NCT01506219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus, the present project aims to examine the effect of home-visit follow-up of older frail patients discharged from the orthopedic ward with a hip fracture. Furthermore, we will explore the effect of a cross-sectorial collaboration between hospital and municipality in the patients' homes to prevent falls, readmissions, medicine-associated adverse effects, and physical deconditioning in old frail patients.
The present study is a interventional trial. The intervention will consist of a home visit within ten weekdays of the discharge, where a comprehensive geriatric assessment (CGA) will be performed. The team performing the CGA consist of a Geriatrician and an experienced geriatric nurse. CGA is an overall assessment of the patient taking account of; the presence and severity of comorbidity, the nutritional state, cognitive and functional status, review of current medications, and social measures. The purpose is to stabilize and optimize current as well as chronic conditions, and reduce the probability of adverse events and falls, and to secure interventions or changes persist through the transition from the secondary to the primary health care system. The assessment may lead to several interventions, including; medicine review (new medicine, change in current or discontinuation), initiation of a nutritional effort or contact to a dietitian, referral to other health care services (outpatient clinics, hospitals, or general practitioner), referral to physiotherapy and/or occupational therapy or optimization of home care.
Patients randomized to the control group will receive standard care, where the subsequent need for medical service or increased home care will require contact with the general practitioner or the municipality, at the patient's initiative.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Geriatric home visit
Home-visit where a comprehensive geriatric assessment will be performed
Home visit and comprehensive geriatric assessment
Home-visit from the geriatric team, who will do a full geriatric assessment and targeted interventions
Standard care
No follow-up.
Control group, no designated follow up
Only follow-up on patients own initiative with contact to the general practitioner
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home visit and comprehensive geriatric assessment
Home-visit from the geriatric team, who will do a full geriatric assessment and targeted interventions
Control group, no designated follow up
Only follow-up on patients own initiative with contact to the general practitioner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hip fracture
* Ability to provide informed consent
* Residence in one of three following municipalities: Gladsaxe, Rudersdal or Lyngby-Taarbæk
Exclusion Criteria
* Patients, who dies within 48 hours of discharge
* Terminal patients
Nursing home residents
70 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martin Schultz
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev and Gentofte hospital
Herlev, Capital Region, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HgH_UGT_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.